the effectiveness of sk and uk in high doses has been demonstrated , in particular in pulmonary embolism and acute arterial obstruction of the limbs , but there is a risk of haemorrhage , whilst uk in moderate doses is usually well tolerated but has yet to prove its effectiveness in randomised double blind trials .
C0034065
pulmonary embolism
C0042071
uk